WASPIP |
IPI00552369 |
GTF3C1 |
IPI00414481 |
3.69 |
Evidence |
|
RB1 |
RB1: Retinoblastoma-associated protein |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
3.69 |
Evidence |
|
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
TGIF2 |
TGIF2: Homeobox protein TGIF2 |
3.69 |
Evidence |
|
WASPIP |
IPI00552369 |
LILRB1 |
IPI00385703 |
3.69 |
Evidence |
|
PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
AHNAK |
AHNAK: AHNAK protein |
3.69 |
Evidence |
|
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
JMJD1A |
JMJD1A, JHDM2A, JMJD1, KIAA0742: JmjC domain-containing histone demethylation pr |
3.69 |
Evidence |
|
WASPIP |
IPI00552369 |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
3.69 |
Evidence |
|
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
RNPS1 |
RNPS1, LDC2: RNA-binding protein with serine-rich domain 1 |
3.69 |
Evidence |
|
CHD4 |
CHD4: Chromodomain-helicase-DNA-binding protein 4 |
CFL1 |
CFL1, CFL: Cofilin-1 |
3.69 |
Evidence |
|
FIGF |
FIGF, VEGFD: Vascular endothelial growth factor D precursor |
CDH5 |
CDH5: Cadherin-5 precursor |
3.69 |
Evidence |
|
LSM1 |
LSM1, CASM: U6 snRNA-associated Sm-like protein LSm1 |
EXOSC8 |
EXOSC8, OIP2, RRP43: Exosome complex exonuclease RRP43 |
3.687 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
IRF1 |
IRF1: Interferon regulatory factor 1 |
3.687 |
Evidence |
|
RNF8 |
RNF8, KIAA0646: E3 ubiquitin-protein ligase RNF8 |
CSE1L |
CSE1L, CAS, XPO2: Exportin-2 |
3.687 |
Evidence |
|
RNF8 |
RNF8, KIAA0646: E3 ubiquitin-protein ligase RNF8 |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
3.687 |
Evidence |
|
XPO1 |
XPO1, CRM1: Exportin-1 |
RNF8 |
RNF8, KIAA0646: E3 ubiquitin-protein ligase RNF8 |
3.687 |
Evidence |
|
LSM2 |
LSM2, C6orf28, G7b: U6 snRNA-associated Sm-like protein LSm2 |
EXOSC8 |
EXOSC8, OIP2, RRP43: Exosome complex exonuclease RRP43 |
3.687 |
Evidence |
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
BIN3 |
BIN3: Bridging integrator 3 |
3.682 |
Evidence |
|
HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
MAP3K10 |
MAP3K10, MLK2, MST: Mitogen-activated protein kinase kinase kinase 10 |
3.68 |
Evidence |
|
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
DAB2 |
DAB2, DOC2: Disabled homolog 2 |
3.68 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
HSPB8 |
HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 |
3.68 |
Evidence |
|
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
PARD3 |
IPI00154915 |
3.68 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
3.68 |
Evidence |
|
CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
3.68 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
3.68 |
Evidence |
|
IRS1 |
IRS1: Insulin receptor substrate 1 |
DUSP4 |
DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4 |
3.68 |
Evidence |
|